Quarterly report pursuant to Section 13 or 15(d)

Stock Warrants (Narrative) (Details)

v2.4.0.8
Stock Warrants (Narrative) (Details) (USD $)
6 Months Ended 0 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2013
Minimum [Member]
Jun. 30, 2013
Maximum [Member]
Jun. 30, 2013
Weighted Average [Member]
Jun. 30, 2013
Series HH Warrants [Member]
Jun. 30, 2013
Five Year Series II Warrants [Member]
Jun. 30, 2013
Five Year Series II Warrants [Member]
Maximum [Member]
Jun. 30, 2013
General Electric Capital Corporation [Member]
Jun. 30, 2013
General Electric Capital Corporation [Member]
Series HH Warrants [Member]
Jun. 24, 2013
Hercules Technology II, L.P. Notes [Member]
Jun. 25, 2013
Hercules Technology II, L.P. Notes [Member]
Jun. 30, 2013
Platinum Montaur Life Sciences, LLC Credit Facility [Member]
Jun. 30, 2013
Platinum Montaur Life Sciences, LLC Credit Facility [Member]
Maximum [Member]
Mar. 31, 2013
Platinum Montaur Life Sciences, LLC Credit Facility [Member]
Series X Warrants [Member]
Jun. 30, 2013
Platinum Montaur Life Sciences, LLC Credit Facility [Member]
Series X Warrants and Series AA Warrants [Member]
Jun. 30, 2013
Preferred Stock [Member]
Jun. 30, 2013
Common Stock [Member]
Class of Warrant or Right [Line Items]                                  
Warrants exercised                           3,000,000 7,733,223    
Issued stock upon exercise of warrants, shares                           3,000,000      
Proceeds from warrant exercises                           $ 1,380,000      
Principal payments on notes payable 5,901,335                 1,300,000 4,400,000 4,781,333          
Number of shares underlying warrant issued                 301,205           7,733,223    
Debt instrument, principal amount               $ 25,000,000       $ 4,781,333 $ 35,000,000        
Warrants outstanding 1,400,000       301,205 275,000                      
Exercise price of warrant issued   1.97 3.04 2.38 2.49   3.04   2.49                
Shares conversion, number of common stock equivalent to each preferred stock                                 3,270
Series B preferred stock issued, shares                               2,364.9